NexgenRx Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was CAD 3.11 million compared to CAD 2.76 million a year ago. Net income was CAD 0.030068 million compared to CAD 0.380106 million a year ago.
For the six months, revenue was CAD 6.29 million compared to CAD 5.56 million a year ago. Net income was CAD 0.408024 million compared to CAD 0.742217 million a year ago. Basic earnings per share from continuing operations was CAD 0.006 compared to CAD 0.011 a year ago. Diluted earnings per share from continuing operations was CAD 0.005 compared to CAD 0.01 a year ago.